tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Hardik Parikh, 6 are a BUY (75%), 2 are a SELL (25%).
Analyst Hardik Parikh, currently employed at JPMORGAN, carries an average stock price target met ratio of 38.89% that have a potential upside of 31.59% achieved within 251 days.
Hardik Parikh’s has documented 15 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GPCR, Structure Therapeutics American Depositary Shares at 21-Jan-2026.
Analyst best performing recommendations are on PCRX (PACIRA PHARMACEUTICALS).
The best stock recommendation documented was for PCRX (PACIRA PHARMACEUTICALS) at 5/16/2025. The price target of $24 was fulfilled within 40 days with a profit of $1.86 (7.19%) receiving and performance score of 1.8.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Dec-2024
$70
$20.29 (40.82%)
$100
1 months 19 days ago
(11-Jun-2026)
3/6 (50%)
$26.7 (61.66%)
229
Buy Since 19-Oct-2023
$113
$63.29 (127.32%)
5 months 3 days ago
(27-Feb-2026)
9/10 (90%)
$50.02 (79.42%)
530
Buy Since 21-May-2024
$105
$55.29 (111.23%)
$65
6 months 8 days ago
(22-Jan-2026)
1/2 (50%)
$13.13 (14.29%)
566
Buy Since 28-Feb-2023
$140
$90.29 (181.63%)
$90
6 months 10 days ago
(20-Jan-2026)
2/3 (66.67%)
$48.98 (53.81%)
190
Buy Since 23-Sep-2024
$125
$75.29 (151.46%)
$120
7 months 18 days ago
(12-Dec-2025)
0/3 (0%)
$57.94 (86.40%)
What Year was the first public recommendation made by Hardik Parikh?
